Similarly, STEAP1 overexpression is linked to poorer overall survival (OS) in colorectal cancer, diffuse large B-cell lymphoma, acute myeloid leukemia, and multiple myeloma [31]. Here, STEAP1 is linked to AL amyloidosis.